Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix

Partners Seek to Develop New Imagining Agents for Cardiovascular Disease Diagnosis

By Medimaging International staff writers
Posted on 09 Dec 2013
Print article
Partners in a recently signed research agreement will be developing new imaging agents for the noninvasive measurement of blood flow in the heart for the diagnosis of cardiovascular diseases–a sector worth of some two billion USD annually.

Hadasit (Jerusalem, Israel), the technology transfer company of the Hadassah Medical Organization (Jerusalem, Israel) announced the initiation of a three-year license and cooperation agreement with Synektik SA (Warsaw, Poland) to develop new imagining agents for use in PET/CT scans, which will enable the quantitative measurement of blood flow to the heart. The potential agents are expected to enable the clinician to determine the extent of damage resulting from a heart attack, and predict the degree of recovery after the heart attack or bypass surgery.

Research will be conducted at the Hadassah Medical Organization in Jerusalem in cooperation with Synektik's new research and development facility in Warsaw. Development funding of four million USD will be provided by Synektik, which will receive a worldwide license for any newly developed imaging agent and will spearhead further development, clinical trials registration, and commercialization.

Dr. Eyal Mishani, director of the cyclotron and radiochemistry unit of the Hadassah Medical Organization, said, "The funding would facilitate pre-clinical research and development stages and preparation for clinical trials which will be performed jointly with Synektik."

Related Links:

Hadasit
Hadassah Medical Organization
Synektik SA



Print article
Radcal

Channels

Radiography

view channel
Image: The CAD platform is available on the Aspire Cristalle digital mammography system (Photo courtesy of Fujifilm).

CAD Solution Available on New Digital Mammography System

An industry-leading provider of cancer detection, radiation therapy, and workflow solutions, has announced that the company's mammography CAD solution is now available on a new advanced Full Field Digital... Read more

Nuclear medicine

view channel
Image: MRV tracing in a mouse thalamus (Photo courtesy of the Salk Institute for Biological Studies).

New Reagent Helps Map Neural Connections in Brain

An improved rabies virus tracer visualizes neural circuitry in the brain, helping to understand more about motor diseases and neurodevelopmental disorders. Researchers at the Salk Institute for Biological... Read more

General/Advanced Imaging

view channel

Early Intervention with Stent Retrievers Improves Outcomes for Ischemic Stroke Patients

New research has shown that restoration of blood flow to the brain within two and a half hours from the onset of the first signs of acute ischemic stroke resulted in none, or only minimal disability in 91% of patients. Endovascular therapy in the early stages of the onset of stroke symptoms significantly improved functional... Read more

Imaging IT

view channel

World Medical VR Technology Company Unveils First-of-Its-Kind Neurosurgery Surgical Visualization Platform

A novel neurosurgery Virtual Reality (VR) visualization platform has been demonstrated at the NVIDIA GPU Technology Conference (GTC) 2016 in California (USA). The enterprise-wide solution is intended to help clinicians plan, prepare, and perform neurosurgery, and enable the surgeon to empower and engage their patients... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.